Novartis acquires a gene-therapy company Gyroscope Therapeutics

Swiss healthcare giant Novartis has agreed to pay $1.5 billion to acquire British biotech company Gyroscope Therapeutics.

Swiss healthcare giant Novartis has agreed to pay $1.5 billion to acquire British biotech company Gyroscope Therapeutics. This acquisition will help the former to expand its offerings to include gene therapies for the eyes. Syncona, Gyroscope’s parent company, found their shares rising by 12.2%

For the deal, Novartis will pay an upfront payment of $800. Scope for further payment of an additional $700 million is possible if Gyroscope fulfils certain milestones. Novartis gets access to Gyroscope's gene therapy for geographic atrophy.

Novartis has been acquiring startups that have the technology to restore vision by gene therapies. Earlier this year, it acquired Arctos Medical and the year before that Vedere Bio Inc. for $280 million.

In recent years, gene therapy has garnered much attention. Pfizer is conducting experiments with gene therapy for a rare neuromuscular disease. One of the problems limiting this field is its high price tag. 

Gene therapies are currently among the world's most expensive drugs. Another drawback of this area is the lack of a safety net. Pfizer had to pull a stop to their experiments due to the deaths of young study subjects.

Tags : #Novartis #Gyroscope #funding #startup #genomics #genetherapy #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024
Empowering Patients: The Role of Advocacy in Indian HealthcareMarch 26, 2024
A New Dawn in Heart Surgery: Mitral Valve Repair for 15-Year-Old PatientMarch 26, 2024
Cracking the Code of Extended Fasting: Lessons from a Comprehensive InvestigationMarch 26, 2024